Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
Pancreatic adenocarcinoma carries a devastating prognosis. For locally advanced and metastatic disease, several chemotherapeutic regimens are currently being used. Over the past years, novel approaches have included targeting EGFR, NTRK, PARP, K-Ras as well as stroma and fibrosis, leading to approva...
Main Authors: | Konstantin Schlick, Dominik Kiem, Richard Greil |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/10/1469 |
Similar Items
-
Cellular landscaping of exosomal miRNAs in cancer metastasis: From chemoresistance to prognostic markers
by: Rahul Bhattacharjee, et al.
Published: (2022-10-01) -
miRNA Predictors of Pancreatic Cancer Chemotherapeutic Response: A Systematic Review and Meta-Analysis
by: Madhav Madurantakam Royam, et al.
Published: (2019-06-01) -
Improving Gemcitabine Sensitivity in Pancreatic Cancer Cells by Restoring miRNA-217 Levels
by: Concetta Panebianco, et al.
Published: (2021-04-01) -
Molecular Investigation of miRNA Biomarkers as Chemoresistance Regulators in Melanoma: A Protocol for Systematic Review and Meta-Analysis
by: Peter Shaw, et al.
Published: (2022-01-01) -
MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
by: Manish K. Pal, et al.
Published: (2015-12-01)